Jesus Alberto Silvas, Ph.D., is a virologist studying viruses that cause hemorrhagic fevers and respiratory illnesses. Dr. Silvas received his Ph.D. in experimental pathology at the University of Texas Medical Branch-Galveston and completed post-doctoral work at Georgia State University. At Texas Biomed’s Maximum Containment Contract Research Laboratory, Dr. Silvas standardizes and develops protocols and assays for studies involving high throughput screening, compound repurposing, and other therapeutic approaches. He joined Texas Biomed in 2020.
Inside the Lab
Dr. Silvas coordinates and conducts experiments performed under the Maximum Containment Contract Research (MCCR) Laboratory directed by Dr. Ricardo Carrion Jr. The team uses the Biosafety Level-3 (BSL-3) and Biosafety Level 4 (BSL-4) laboratories to safely conduct studies seeking to understand the molecular pathogenesis of high consequence pathogens such as Filoviruses (Ebola and Marburg viruses), Arenaviruses (Lassa virus), Bunyaviruses (Crimean Congo Hemorrhagic Fever virus), and Coronaviruses (SARS-CoV-2).
Dr. Silvas also participates in the generating and characterizing virus stocks and lab assays for use in studies. In addition to the work inside the laboratory, he prepares study protocols and interprets, analyzes, documents, and reports results for studies performed in collaboration with government and private sponsors.